BFAC vs. ENGN, NETD, SCRM, RRAC, CDRO, IPXX, KAII, AIRJ, XPAX, and PRPB
Should you be buying Battery Future Acquisition stock or one of its competitors? The main competitors of Battery Future Acquisition include enGene (ENGN), Nabors Energy Transition Corp. II (NETD), Screaming Eagle Acquisition (SCRM), Rigel Resource Acquisition (RRAC), Codere Online Luxembourg (CDRO), Inflection Point Acquisition Corp. II (IPXX), Kismet Acquisition Two (KAII), Montana Technologies (AIRJ), Zalatoris II Acquisition (XPAX), and CC Neuberger Principal Holdings II (PRPB).
Battery Future Acquisition (NYSE:BFAC) and enGene (NASDAQ:ENGN) are both small-cap unclassified companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.
Battery Future Acquisition has a beta of -0.02, suggesting that its stock price is 102% less volatile than the S&P 500. Comparatively, enGene has a beta of -0.4, suggesting that its stock price is 140% less volatile than the S&P 500.
In the previous week, enGene had 21 more articles in the media than Battery Future Acquisition. MarketBeat recorded 22 mentions for enGene and 1 mentions for Battery Future Acquisition. Battery Future Acquisition's average media sentiment score of 0.80 beat enGene's score of -0.02 indicating that Battery Future Acquisition is being referred to more favorably in the media.
enGene's return on equity of 0.00% beat Battery Future Acquisition's return on equity.
enGene has a consensus price target of $34.40, indicating a potential upside of 291.35%. Given enGene's higher probable upside, analysts plainly believe enGene is more favorable than Battery Future Acquisition.
enGene received 7 more outperform votes than Battery Future Acquisition when rated by MarketBeat users.
74.7% of Battery Future Acquisition shares are owned by institutional investors. Comparatively, 64.2% of enGene shares are owned by institutional investors. 65.4% of Battery Future Acquisition shares are owned by company insiders. Comparatively, 13.7% of enGene shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Battery Future Acquisition beats enGene on 6 of the 11 factors compared between the two stocks.
Get Battery Future Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for BFAC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BFAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Battery Future Acquisition Competitors List
Related Companies and Tools
